HK1074011A1 - Preparation for wound healing and prevention of bandage adhesion to the wound - Google Patents

Preparation for wound healing and prevention of bandage adhesion to the wound

Info

Publication number
HK1074011A1
HK1074011A1 HK05105224A HK05105224A HK1074011A1 HK 1074011 A1 HK1074011 A1 HK 1074011A1 HK 05105224 A HK05105224 A HK 05105224A HK 05105224 A HK05105224 A HK 05105224A HK 1074011 A1 HK1074011 A1 HK 1074011A1
Authority
HK
Hong Kong
Prior art keywords
wound
prevention
preparation
wound healing
adhesion
Prior art date
Application number
HK05105224A
Other languages
English (en)
Inventor
Vladimir Velebny
Lubos Sobotka
Stanislav Pavek
Jana Ruzickova
Original Assignee
Cpn Spol Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5475977&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1074011(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cpn Spol Sro filed Critical Cpn Spol Sro
Publication of HK1074011A1 publication Critical patent/HK1074011A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
HK05105224A 2002-01-18 2005-06-22 Preparation for wound healing and prevention of bandage adhesion to the wound HK1074011A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ200212746U CZ12015U1 (cs) 2002-01-18 2002-01-18 Přípravek pro prevenci adheze bandáľe na ránu
PCT/CZ2003/000003 WO2003059404A2 (en) 2002-01-18 2003-01-15 Preparation for wound healing and prevention of bandage adhesion to the wound

Publications (1)

Publication Number Publication Date
HK1074011A1 true HK1074011A1 (en) 2005-10-28

Family

ID=5475977

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05105224A HK1074011A1 (en) 2002-01-18 2005-06-22 Preparation for wound healing and prevention of bandage adhesion to the wound

Country Status (21)

Country Link
US (1) US20050181025A1 (ru)
EP (1) EP1487506B1 (ru)
JP (1) JP2005514445A (ru)
KR (1) KR100923122B1 (ru)
CN (1) CN1298394C (ru)
AT (1) ATE358501T1 (ru)
AU (1) AU2003206611B2 (ru)
BR (1) BR0302967A (ru)
CA (1) CA2470639C (ru)
CZ (1) CZ12015U1 (ru)
DE (1) DE60312969T2 (ru)
DK (1) DK1487506T3 (ru)
ES (1) ES2285092T3 (ru)
HK (1) HK1074011A1 (ru)
IL (1) IL162801A (ru)
MX (1) MXPA04006907A (ru)
PT (1) PT1487506E (ru)
RU (1) RU2296569C2 (ru)
UA (1) UA78264C2 (ru)
WO (1) WO2003059404A2 (ru)
ZA (1) ZA200404832B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2308954C2 (ru) 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
US20080241270A1 (en) * 2007-03-30 2008-10-02 Neal Robert A Fluid composition for inhibiting surgical adhesion formation and related method of production
CZ303471B6 (cs) * 2007-10-03 2012-10-03 Contipro Biotech S.R.O. Prípravek pro hojení ran a prevenci adheze bandáže na ránu obsahující chitosan-glukan
GB201004072D0 (en) * 2010-03-11 2010-04-28 Turzi Antoine Process, tube and device for the preparation of wound healant composition
CN102258800B (zh) * 2010-05-25 2015-04-08 上海建华精细生物制品有限公司 一种复方创愈凝胶
CZ303548B6 (cs) 2011-01-05 2012-11-28 Contipro Pharma A.S. Zdravotní prípravek tvorící jód, zpusob jeho prípravy a bandáž, která jej obsahuje
WO2016021215A1 (ja) * 2014-08-08 2016-02-11 日医工株式会社 ヨウ化カリウムゼリー状医薬組成物
CZ307615B6 (cs) * 2017-06-05 2019-01-16 Contipro A.S. Antimikrobiální kompozice obsahující polysacharid, stabilizátor a trijodid, způsob její přípravy a použití
KR20190012120A (ko) * 2017-07-26 2019-02-08 (주)유레 히알루론산-칼슘 및 폴리라이신을 포함하는 창상 피복재 및 그 제조 방법
CZ2018428A3 (cs) * 2018-08-23 2019-12-04 Contipro As Kompozice obsahující jodid a derivát kyseliny hyaluronové s oxidačním účinkem, způsob její přípravy a použití
CN111978600B (zh) * 2020-09-02 2022-07-01 山东华熙海御生物医药有限公司 一种用于安抚奶嘴的透明质酸复合凝胶

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
GB9514361D0 (en) * 1995-07-13 1995-09-13 Bristol Myers Squibb Co A film for topical use in the treatment of wounds
JP3748970B2 (ja) * 1997-01-31 2006-02-22 電気化学工業株式会社 ヒアルロン酸ナトリウム含有水溶液
JP3472442B2 (ja) * 1997-06-05 2003-12-02 東亜薬品株式会社 損傷皮膚修復用製剤
EP0920875A1 (en) * 1997-06-18 1999-06-09 JAPAN as repr. by DIR. GENERAL of NATIONAL INST. OF SERICULTURAL & ENTOMOLOGICAL SCIENCE MINISTRY OF AGR, FORESTRY & FISHERI Wound covering material containing silk fibroin and silk sericin as the main components and process for producing the same
EP1005874B1 (en) * 1997-08-22 2005-05-18 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for producing the same and medical material containing the same
US6015836A (en) * 1997-10-28 2000-01-18 Martin; Howard Chemical disinfectant employing dual chain quaternary ammonium compounds with iodine
JP2000319171A (ja) * 1999-03-03 2000-11-21 Nof Corp 殺菌性皮膚外用剤組成物
US20020037319A1 (en) * 1999-11-08 2002-03-28 Alan Drizen Drug preparations
CN1136012C (zh) * 2000-08-07 2004-01-28 黄玲惠 伤口敷料及其制备方法
US20030054025A1 (en) * 2001-09-14 2003-03-20 3M Innovative Properties Company Non-contact printing method for making a medical pressure sensitive adhesive article

Also Published As

Publication number Publication date
MXPA04006907A (es) 2005-04-19
ATE358501T1 (de) 2007-04-15
DE60312969T2 (de) 2007-12-13
ES2285092T3 (es) 2007-11-16
PT1487506E (pt) 2007-07-13
CN1615159A (zh) 2005-05-11
ZA200404832B (en) 2005-07-27
KR20040081128A (ko) 2004-09-20
DK1487506T3 (da) 2007-08-06
RU2296569C2 (ru) 2007-04-10
IL162801A0 (en) 2005-11-20
RU2004124041A (ru) 2005-04-20
WO2003059404A2 (en) 2003-07-24
UA78264C2 (en) 2007-03-15
CA2470639A1 (en) 2003-07-24
CZ12015U1 (cs) 2002-02-25
AU2003206611B2 (en) 2007-03-29
CN1298394C (zh) 2007-02-07
DE60312969D1 (de) 2007-05-16
CA2470639C (en) 2009-12-22
US20050181025A1 (en) 2005-08-18
KR100923122B1 (ko) 2009-10-23
AU2003206611A1 (en) 2003-07-30
EP1487506B1 (en) 2007-04-04
IL162801A (en) 2008-06-05
JP2005514445A (ja) 2005-05-19
BR0302967A (pt) 2004-07-06
EP1487506A2 (en) 2004-12-22
WO2003059404A3 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
HK1074011A1 (en) Preparation for wound healing and prevention of bandage adhesion to the wound
NZ533252A (en) Treatment of wounds and compositions employed
GB0105772D0 (en) Use
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
GB2352972A (en) Use of dexmedetomidine for icu sedation
SI1638582T1 (sl) Uporaba hialuronske kisline za pripravo sestav za zdravljenje ponavljajoäśih se aft v ustni votlini
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy
AU2003269266A1 (en) Transparent gel composition, for the administration of diclofenac sodium through the skin
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
AU2003226276A1 (en) Oxygen enriched implant for orthopedic wounds
AU2003255287A1 (en) Use of a proteasome inhibitor in the treatment of fibrotic diseases
AU2003238844A1 (en) Labial product system to maintain a treatment agent
LT2007045A (en) Preparation for wound healing and prevention of bandage adhesion to the wound
GEP20084463B (en) Use of the distrontium salt of the acid 2-[n,n-di(carboxy methyl) amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain
AU2003281257A1 (en) A novel use of rapamycin and structural analogues thereof
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
GR1004434B (el) Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
WO2003103681A3 (de) Verwendung von oral verfügbaren prostazyklinderivaten für die herstellung eines arzneimittels zur behandlung von krankheiten, die mit knochenmarködemen assoziiert sind
MXPA03010919A (es) Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
AU2003297807A1 (en) Use of n-chlorotaurine for treatment of oozing tissue deficiencies
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
SI1487506T1 (sl) Pripavek za zdravljenje ran in za preventivo sprijemanja povoja z rano

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120115